Osteoarthritis gene therapy injection advances to human clinical trials following successful animal testing

Researchers have developed a single-injection therapy that reversed osteoarthritis in animal models, prompting regulatory approval for human clinical trials. While the efficacy and safety profile in humans remain unproven, the transition to clinical testing marks a significant milestone in regenerative medicine for joint disease.